112 related articles for article (PubMed ID: 17223371)
1. Accumulation of Epstein-Barr virus (EBV) BMRF1 protein EA-D during latent EBV activation of Burkitt's lymphoma cell line Raji.
Ohashi M; Horie K; Hoshikawa Y; Nagata K; Osaki M; Ito H; Sairenji T
Microbes Infect; 2007 Feb; 9(2):150-9. PubMed ID: 17223371
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
3. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
4. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
5. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
Gradoville L; Grogan E; Taylor N; Miller G
Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
[TBL] [Abstract][Full Text] [Related]
6. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
Flamand L; Stefanescu I; Ablashi DV; Menezes J
J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
[TBL] [Abstract][Full Text] [Related]
9. Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products.
Takagi S; Takada K; Sairenji T
Virology; 1991 Nov; 185(1):309-15. PubMed ID: 1656589
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
Lidin B; Lamon EW
Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
[TBL] [Abstract][Full Text] [Related]
11. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
12. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of spontaneous Epstein-Barr virus reactivation in the P3HR-1 cell line by L-arginine.
Agawa H; Ikuta K; Minamiyama Y; Inoue M; Sairenji T
Virology; 2002 Dec; 304(1):114-24. PubMed ID: 12490409
[TBL] [Abstract][Full Text] [Related]
14. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
Takada K; Ji Z; Fujiwara S; Shimizu N; Tanabe-Tochikura A
J Virol; 1992 Sep; 66(9):5590-3. PubMed ID: 1323712
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
Srinivas SK; Sample JT; Sixbey JW
J Infect Dis; 1998 Jun; 177(6):1705-9. PubMed ID: 9607853
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
Iwakiri D; Takada K
J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
20. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
Adamson AL; Kenney SC
Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
